Miranda Thomas

6.4k total citations · 2 hit papers
70 papers, 5.2k citations indexed

About

Miranda Thomas is a scholar working on Molecular Biology, Epidemiology and Oncology. According to data from OpenAlex, Miranda Thomas has authored 70 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 34 papers in Epidemiology and 24 papers in Oncology. Recurrent topics in Miranda Thomas's work include Cervical Cancer and HPV Research (30 papers), Cancer-related Molecular Pathways (22 papers) and Hippo pathway signaling and YAP/TAZ (15 papers). Miranda Thomas is often cited by papers focused on Cervical Cancer and HPV Research (30 papers), Cancer-related Molecular Pathways (22 papers) and Hippo pathway signaling and YAP/TAZ (15 papers). Miranda Thomas collaborates with scholars based in Italy, United States and United Kingdom. Miranda Thomas's co-authors include Lawrence Banks, David Pim, Greg Matlashewski, Ann Kalita, Paola Massimi, Alan Storey, Catherine Harwood, Sylvie Labrecque, Daniela Gardiol and Judith Breuer and has published in prestigious journals such as Nature, Nucleic Acids Research and Journal of Clinical Oncology.

In The Last Decade

Miranda Thomas

66 papers receiving 5.1k citations

Hit Papers

Role of a p53 polymorphism in the development of human pa... 1998 2026 2007 2016 1998 1999 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miranda Thomas Italy 33 2.5k 2.4k 2.4k 769 712 70 5.2k
Paola Massimi Italy 36 1.6k 0.6× 1.6k 0.7× 1.1k 0.4× 685 0.9× 435 0.6× 86 3.4k
David Pim Italy 25 1.6k 0.6× 1.2k 0.5× 1.5k 0.6× 480 0.6× 507 0.7× 40 3.1k
L. Crawford United Kingdom 33 1.8k 0.7× 2.1k 0.9× 2.0k 0.9× 1.3k 1.7× 459 0.6× 67 4.6k
G W Demers United States 23 1.8k 0.7× 972 0.4× 1.7k 0.7× 700 0.9× 409 0.6× 29 3.6k
Elliot J. Androphy United States 52 5.8k 2.3× 3.0k 1.2× 1.6k 0.7× 1.9k 2.4× 471 0.7× 155 9.1k
Carole Yee United States 29 1.3k 0.5× 1.9k 0.8× 1.3k 0.5× 962 1.3× 248 0.3× 59 4.1k
Carl C. Baker United States 35 2.8k 1.1× 1.9k 0.8× 825 0.3× 1.4k 1.8× 399 0.6× 55 4.9k
N L Hubbert United States 25 1.5k 0.6× 2.6k 1.1× 988 0.4× 962 1.3× 218 0.3× 30 4.2k
D. Pim Italy 20 1.6k 0.7× 891 0.4× 2.2k 0.9× 1.1k 1.5× 438 0.6× 23 3.8k
Martin J. Allday United Kingdom 45 1.9k 0.8× 1.4k 0.6× 4.2k 1.8× 404 0.5× 532 0.7× 73 5.5k

Countries citing papers authored by Miranda Thomas

Since Specialization
Citations

This map shows the geographic impact of Miranda Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miranda Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miranda Thomas more than expected).

Fields of papers citing papers by Miranda Thomas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miranda Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miranda Thomas. The network helps show where Miranda Thomas may publish in the future.

Co-authorship network of co-authors of Miranda Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Miranda Thomas. A scholar is included among the top collaborators of Miranda Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miranda Thomas. Miranda Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thomas, Miranda, et al.. (2021). Inhibition of kinase IKKβ suppresses cellular abnormalities induced by the human papillomavirus oncoprotein HPV 18E6. Scientific Reports. 11(1). 1111–1111. 5 indexed citations
2.
Boon, Siaw Shi, Priscilla T. Y. Law, Zigui Chen, et al.. (2019). Oncogenicitiy Comparison of Human Papillomavirus Type 52 E6 Variants. Journal of General Virology. 100(3). 484–496. 9 indexed citations
3.
Gilbert, Mary, et al.. (2016). A Drosophila Model of HPV E6-Induced Malignancy Reveals Essential Roles for Magi and the Insulin Receptor. PLoS Pathogens. 12(8). e1005789–e1005789. 11 indexed citations
4.
Banks, Lawrence, David Pim, & Miranda Thomas. (2012). Human tumour viruses and the deregulation of cell polarity in cancer. Nature reviews. Cancer. 12(12). 877–886. 50 indexed citations
5.
Pim, David, Martina Bergant, Siaw Shi Boon, et al.. (2012). Human papillomaviruses and the specificity of PDZ domain targeting. FEBS Journal. 279(19). 3530–3537. 72 indexed citations
6.
Thomas, Miranda, J. Dasgupta, Yi Zhang, Xiaojiang Chen, & Lawrence Banks. (2008). Analysis of specificity determinants in the interactions of different HPV E6 proteins with their PDZ domain-containing substrates. Virology. 376(2). 371–378. 40 indexed citations
7.
Ivanova, Saška, Miranda Thomas, Ernesto Guccione, et al.. (2006). Cleavage of MAGI-1, a tight junction PDZ protein, by caspases is an important step for cell-cell detachment in apoptosis. APOPTOSIS. 12(2). 343–354. 24 indexed citations
8.
Ivanova, Saška, et al.. (2005). hDLG/SAP97, a member of the MAGUK protein family, is a novel caspase target during cell-cell detachment in apoptosis. Biological Chemistry. 386(7). 705–10. 18 indexed citations
9.
Thomas, Miranda & Lawrence Banks. (2005). In Vitro Assays of Substrate Degradation Induced by High-Risk HPV E6 Oncoproteins. Humana Press eBooks. 119. 411–418. 5 indexed citations
10.
Massimi, Paola, Noor Gammoh, Miranda Thomas, & Lawrence Banks. (2004). HPV E6 specifically targets different cellular pools of its PDZ domain-containing tumour suppressor substrates for proteasome-mediated degradation. Oncogene. 23(49). 8033–8039. 102 indexed citations
11.
Pim, David, Miranda Thomas, & Lawrence Banks. (2002). Chimaeric HPV E6 proteins allow dissection of the proteolytic pathways regulating different E6 cellular target proteins. Oncogene. 21(53). 8140–8148. 29 indexed citations
12.
Thomas, Miranda, Richard Laura, Ernesto Guccione, et al.. (2002). Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradation. Oncogene. 21(33). 5088–5096. 166 indexed citations
13.
Thomas, Miranda, et al.. (2001). HPV E6 and MAGUK protein interactions: determination of the molecular basis for specific protein recognition and degradation. Oncogene. 20(39). 5431–5439. 92 indexed citations
14.
Jackson, Sarah, Catherine Harwood, Miranda Thomas, Lawrence Banks, & Alan Storey. (2000). Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins. Genes & Development. 14(23). 3065–3073. 249 indexed citations
15.
Pim, David, et al.. (2000). HPV E6 targeted degradation of the discs large protein: evidence for the involvement of a novel ubiquitin ligase. Oncogene. 19(6). 719–725. 85 indexed citations
16.
Thomas, Miranda, Ann Kalita, Sylvie Labrecque, et al.. (1999). Two Polymorphic Variants of Wild-Type p53 Differ Biochemically and Biologically. Molecular and Cellular Biology. 19(2). 1092–1100. 603 indexed citations breakdown →
17.
Thomas, Miranda, David Pim, & Lawrence Banks. (1999). The role of the E6-p53 interaction in the molecular pathogenesis of HPV. Oncogene. 18(53). 7690–7700. 354 indexed citations
18.
Thomas, Miranda & Lawrence Banks. (1998). Inhibition of Bak-induced apoptosis by HPV-18 E6. Oncogene. 17(23). 2943–2954. 228 indexed citations
19.
Michán, Carmen, et al.. (1997). DNA binding and DNA bending by the MelR transcription activator protein from Escherichia coli. Nucleic Acids Research. 25(9). 1685–1693. 32 indexed citations
20.
Williams, Anthony T., Connie J. Sexton, Karin J. Purdie, et al.. (1994). Retention of low copy number human papillomavirus DNA in cultured cutaneous and mucosal wart keratinocytes. Journal of General Virology. 75(3). 505–511. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026